Source: Virtual Congress 2021 – Long COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
A. Frizzelli (Parma, Italy), M. Aiello (Parma, Italy), L. Calzetta (Parma, Italy), P. Mori (Parma, Italy), L. Marchi (Parma, Italy), V. Alfieri (Parma, Italy), N. Sverzellati (Parma, Italy), M. Majori (Parma, Italy), A. Chetta (Parma, Italy). Predicting factors of pulmonary functional sequelae in COVID-19 patients after 4 months from hospital admission. 1157

Member's Comments

No comment yet.

Related content which might interest you: EABPCO-CPHG study: Prognosis factors of death and/or hospital admission in 1,142 patients, at 3 months after their admission to the pneumology department of a French general hospital for COPD acute exacerbation (AE) Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment Source: Eur Respir J, 58 (2) 2101033; 10.1183/13993003.01033-2021 Year: 2021 Early admission predictors in COPD patients admitted at hospital for an exacerbation Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment? Source: Eur Respir J, 58 (2) 2100785; 10.1183/13993003.00785-2021 Year: 2021 Influences on re-admission of COPD patients to hospital after pulmonary rehabilitation Source: Eur Respir J 2004; 24: Suppl. 48, 661s Year: 2004 Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Abnormal pulmonary function in COVID-19 patients at time of hospital discharge Source: Eur Respir J, 55 (6) 2001217; 10.1183/13993003.01217-2020 Year: 2020 To establish the characteristics which influence patients with an acute exacerbation of COPD to die within 2 weeks of hospital admission compared to those after a 2-week period Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005 Does admission from different sources influence ICU outcome in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006 Early discharge and homecare support for patients with pulmonary disease requiring hospitalization in a respiratory ward Source: Eur Respir J 2005; 26: Suppl. 49, 528s Year: 2005 Risk factors of ICU admission and death among hospitalized patients with Influenza(H1N1) Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011 Comparison of two models of factors associated to hospital admission for COPD Source: Annual Congress 2011 - COPD management Year: 2011 Identifying COPD patients at risk of frequent hospital admission Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006 Factors related to hospital stay of patients with pulmonary thromboembolism Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Pulmonary function and tomographic features of COVID-19 survivors 2 months after hospital discharge: a cohort study Source: Virtual Congress 2021 – Long COVID - 19 Year: 2021 Evaluation of pulmonary rehabilitation to reduce hospital admissions in COPD patients Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Factors determining duration of hospital stay in patients hospitalized for acute COPD exacerbation Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Clinical and biologic risk factors for mortality in the first 6 months of SARS-Cov2 in a Romanian hospital Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021